¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"muscular type of vein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • wedged hepatic vein pressure
    ½û±â°£Á¤¸Æ¾Ð
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • popliteal vein
    ¿À±ÝÁ¤¸Æ
  • popliteal vein
    ½½¿ÍÁ¤¸Æ(ã£èÀð¡Øæ)
  • portal vein
    °£¹®¸Æ
  • portal vein
    ¹®¸Æ(Ú¦Øæ)
  • portal vein thrombosis
    ¹®(¸Æ)Á¤¸Æ Ç÷Àü
  • portal vein ³ª vena portae
    ¹®¸Æ(Ú¦Øæ).
  • posterior auricular vein
    µÚ±Ó¹ÙÄûÁ¤¸Æ, ÈÄÀ̰³Á¤¸Æ(¡­ð¡Øæ).
  • posterior auricular vein
    µÚ±Ó¹ÙÄûÁ¤¸Æ
  • posterior auricular vein
    µÚõ¤aÄûÁ¤¸Æ, ÈÄÀ̰³Á¤¸Æ(¡­ð¡Øæ).
  • posterior cardinal vein
    µÚ±âº»Á¤¸Æ
  • posterior circumflex humeral vein
    µÚÀ§ÆÈÈÖµ¹ÀÌÁ¤¸Æ
  • posterior facial vein
    µÚ¾ó±¼Á¤¸Æ, ÈľȸéÁ¤¸Æ(ý­äÔØüð¡Øæ).
  • posterior facial vein
    µÚ¾ó°ùøþ? ÈľȸéÁ¤¸Æ(ý­äÔØüð¡Øæ).
  • posterior interventricular vein
    µÚ½É½Ç»çÀÌÁ¤¸Æ
  • posterior temporal diploic vein
    µÚ°üÀÚÆÇ»çÀÌÁ¤¸Æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • triangle, muscular
    ±Ù»ï°¢
  • aberrant type
    ÀÌÇü(ì¶úþ)
  • abortive type
    ºÎÀüÇü(ÝÕîïúþ).
  • acute fulminating type
    ±Þ¼º Àü°ÝÇü.
  • agammaglobulinemia,x-linked, bruton type
    ¼º¿°»öü ¿¬°ü¼º, ºê·çÅæÇü(àõæøßäô÷ æáμàõ, ¡­úþ)
  • anovulatory type
    ¹«¹è¶õÇü
  • association type
    ¿¬»óÀ¯Çü
  • asthenia type
    ¹«·ÂüÇü.
  • atypical type
    ºñÁ¤Çü ÇüÅÂ
  • bell type
    Á¾¸ð¾ç, Á¾Çü.
  • blood group =b. type
    Ç÷¾×Çü(Ì´ËâÌ´).
  • blood group =b. type
    Ç÷¾×Çü(úìäûû¡).
  • blood type
    Ç÷¾×Çü(Ì´ËâÌ´).
  • blood type
    Ç÷¾×Çü(úìäûúþ)
  • body type
    üÇü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Inferior choroidal vein
    ¾Æ·¡¸Æ¶ôÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇϸƶôÁ¤¸Æ
  • Inferior basal vein
    ¾Æ·¡¹Ù´ÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇÏÆóÀúÁ¤¸Æ
  • Inferior epigastric vein
    ¾Æ·¡¹èº®Á¤¸Æ
    [¿¾ ¿ë¾î] ÇϺ¹º®Á¤¸Æ
  • Inferior anastomotic vein
    ¾Æ·¡¿¬°áÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇϹ®ÇÕÁ¤¸Æ
  • Right inferior pulmonary vein
    ¾Æ·¡¿À¸¥ÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ìÇÏÆóÁ¤¸Æ
  • Left inferior pulmonary vein
    ¾Æ·¡¿ÞÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ÁÂÇÏÆóÁ¤¸Æ
  • Retromandibular vein
    ¾Æ·¡ÅεÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇϾÇÈÄÁ¤¸Æ
  • Median antebrachial vein
    ¾Æ·¡ÆÈÁß°£Á¤¸Æ
    [¿¾ ¿ë¾î] Àü¿ÏÁ¤ÁßÇÇÁ¤¸Æ
  • Inferior laryngeal vein
    ¾Æ·¡ÈĵÎÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇÏÈĵÎÁ¤¸Æ
  • Vein of vestibular aqueduct
    ¾È¶ã¼öµµ°üÁ¤¸Æ
    [¿¾ ¿ë¾î] ÀüÁ¤¼ö°üÁ¤¸Æ
  • Vestibular vein
    ¾È¶ãÁ¤¸Æ
    [¿¾ ¿ë¾î] ÀüÁ¤Á¤¸Æ
  • Medial circumflex femoral vein
    ¾ÈÂʳҴٸ®ÈÖµ¹ÀÌÁ¤¸Æ
    [¿¾ ¿ë¾î] ³»Ãø´ëÅðȸ¼±Á¤¸Æ
  • Medial marginal vein
    ¾ÈÂʸ𼭸®Á¤¸Æ
    [¿¾ ¿ë¾î] ³»Ãø¿¬Á¤¸Æ
  • Anterior temporal diploic vein
    ¾Õ°üÀÚÆÇ»çÀÌÁ¤¸Æ
    [¿¾ ¿ë¾î] ÀüÃøµÎÆÇ°£Á¤¸Æ
  • Anterior cardinal vein
    ¾Õ±âº»Á¤¸Æ
    [¿¾ ¿ë¾î] ÀüÁÖÁ¤¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
PMA index of prevalence and severity of gingivitis, where P = papillary gingiva, M = marginal gingiva, a...
PMD Pelizaeus-Merzbacher disease; posterior mandibular depth; primary myocardial disease; private medici...
PMR patient meta-record; perinatal mortality rate; periodic medical review; physical medicine and rehabi...
PPMA progressive postmyelitis muscular atrophy
PSMA proximal spinal muscular atrophy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
H.U.V. Human Umbilical Vein
HUVEC Human Umbilical Vein Endothelial Cells
HSVEC Human saphenous vein endothelial cells
HUVEC Human umbilical cord vein endothelial cell
HUVEC Human umbilical vein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • inferior thalamostriate vein
    ¾Æ·¡ ½Ã»ó ÁÙ¹«´Ìü Á¤¸Æ
  • internal jugular vein
    ³»°æÁ¤¸Æ
  • jugular vein
    °æÁ¤¸Æ
    ÇϾǰ¢ ÈĹæÀÇ ÀÌÇϼ±¿¡¼­ ÇϾÇÈÄ Á¤¸Æ°ú ÈÄÀ̰³ Á¤¸ÆÀÌ ¸¸³ª Çü¼ºµÇ¸ç. °æºÎ¸¦ Çϰ­ÇÏ¿© ¼â°ñÇÏ Á¤¸Æ, ³»°æ Á¤¸Æ ȤÀº ¿ÏµÎ Á¤¸ÆÀ¸·Î °³±¸ÇÑ´Ù.
  • labyrinthine vein
    ¹Ì·ÎÁ¤¸Æ
  • lacrimal vein
    ´«¹° »ù Á¤¸Æ
  • left gastro-omentalepiploic vein
    ¿Þ À§ ±×¹°¸· Á¤¸Æ
  • left inferior pulmonary vein
    ¾Æ·¡ ¿Þ ÇãÆÄ Á¤¸Æ
  • left renal vein
    ¿Þ ÄáÆÏ Á¤¸Æ
  • left suprarenal vein
    ¿Þ ºÎ½Å Á¤¸Æ
  • left umbilical vein
    ¿Þ ¹è²Å Á¤¸Æ
  • mastoid emissary vein
    À¯µ¹±â µµÃâ Á¤¸Æ, À¯µ¹ µµÃâ µ¿¸Æ, À¯¾ç µ¹±â µµÃâ Á¤¸Æ
    À¯µ¹°øÀ» Áö³ª¸ç, S»ó Á¤¸Æµ¿À» ÈĵΠÁ¤¸Æµ¿ ȤÀº ÈÄÀ̰³ Á¤¸Æ°ú ¿¬°áÇÏ´Â Á¤¸Æ.
  • maxillary vein
    »ó¾ÇÁ¤¸Æ, À§ÅÎ Á¤¸Æ
    À͵¹±Ù Á¤¸ÆÃÑ¿¡¼­ÀÇ Á¤¸Æ. ´ë°³ ÇϳªÀÇ ÂªÀº Á¤¸ÆÀ» Çü¼ºÇϸç ÈĹæÀ¸·Î ÁÖÇàÇÏ¿© ÀÌÇϼ±ÀÇ ÃµÃøµÎ Á¤¸Æ°ú ¸¸³ª ÇϾÇÈÄ Á¤¸ÆÀ» Çü¼ºÇÑ´Ù.
  • medial atrial vein of lateral ventricle
    °¡ÂÊ ³ú½Ç ¾ÈÂÊ º® Á¤¸Æ
  • medial circumflex femoral vein
    ¾ÈÂÊ ³Ò´Ù¸® ÈÖµ¹ÀÌ Á¤¸Æ
    ³»Ãø ´ëÅð ȸ¼± µ¿¸ÆÀÇ ¹ÝÇà Á¤¸ÆÀ̸ç, ´ëÅð Á¤¸Æ ȤÀº ½É´ëÅð Á¤¸ÆÀ¸·Î °³±¸ÇÑ´Ù.
  • median antebrachial vein
    ¾Æ·¡ ÆÈ Áß°£ Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
river-type fish <marine biology> Anadromous fish that rear for a year or more in rivers.
(23 Aug 1998)
Romanovsky type stain <technique> Composite histological stains including methylene blue, Azure A or B and eosin, sometimes with other stains.
Examples are Giemsa, Wright's and Leishman's stain.
(18 Nov 1997)
wild type <genetics> The naturally-occuring, normal, non-mutated version of a gene.
The original parent strain of a virus, bacteria, fruit fly, mouse, or other laboratory test organism. Often refers to how organisms are found naturally, in the wild, before mutations were induced by researchers.
(09 Oct 1997)
wild-type strain A strain found in nature or a standard strain.
See: auxotrophic strains, prototrophic strains.
(05 Mar 2000)
MPGN type i A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure. Membranoproliferative glomerulonephritis (MPGN) has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
(27 Sep 1997)
mpgn type II A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure. Membranoproliferative glomerulonephritis (MPGN) has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
(27 Sep 1997)
woodbury-type 1. A process in photographic printing, in which a relief pattern in gelatin, which has been hardened after certain operations, is pressed upon a plate of lead or other soft metal. An intaglio impression in thus produced, from which pictures may be directly printed, but by a slower process than in common printing.
2. A print from such a plate.
Origin: After the name of the inventor, W. Woodbury.
Source: Websters Dictionary
(01 Mar 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
multiple lipoprotein-type hyperlipidaemia <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease.
Origin: Gr. Haima = blood
(27 Sep 1997)
contact-type dermatitis Dermatitis resembling contact dermatitis or eczema, but caused by an ingested or injected allergen, usually a drug, and with a widespread or generalised distribution.
(05 Mar 2000)
Cowdry's type A inclusion bodies Droplet-like masses of acidophilic material surrounded by clear halos within nuclei, with margination of chromatin on the nuclear membrane.
(05 Mar 2000)
Cowdry's type B inclusion bodies Droplet-like masses of acidophilic material surrounded by clear halos within nuclei, without other nuclear changes during early stages of development of the inclusion.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á